MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 260 filers reported holding MYRIAD GENETICS INC in Q2 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $207,000 | -46.2% | 7,106 | -15.0% | 0.00% | -50.0% |
| Q3 2018 | $385,000 | -8.1% | 8,364 | -25.4% | 0.00% | 0.0% |
| Q2 2018 | $419,000 | -40.3% | 11,216 | -52.8% | 0.00% | -33.3% |
| Q1 2018 | $702,000 | +173.2% | 23,760 | +216.9% | 0.00% | +200.0% |
| Q4 2017 | $257,000 | -4.5% | 7,497 | +0.8% | 0.00% | 0.0% |
| Q3 2017 | $269,000 | -70.6% | 7,435 | -79.0% | 0.00% | -75.0% |
| Q2 2017 | $915,000 | +342.0% | 35,406 | +258.0% | 0.00% | +300.0% |
| Q4 2013 | $207,000 | – | 9,890 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |